Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 390

1.

A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy.

Saint-Marc T, Partisani M, Poizot-Martin I, Bruno F, Rouviere O, Lang JM, Gastaut JA, Touraine JL.

AIDS. 1999 Sep 10;13(13):1659-67.

PMID:
10509567
3.

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA.

AIDS. 1998 May 7;12(7):F51-8.

PMID:
9619798
4.

Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Nolan D, Hammond E, James I, McKinnon E, Mallal S.

Antivir Ther. 2003 Dec;8(6):617-26.

PMID:
14760896
5.

Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.

Tavassoli N, Bagheri H, Sommet A, Delpierre C, Marion-Latard F, Massip P, Aquilina C, Bonnet E, Obadia M, Labau E, Montastruc JL, Bernard J.

Pharmacotherapy. 2006 Feb;26(2):154-61.

PMID:
16466321
6.

Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.

Kosmiski LA, Kuritzkes DR, Lichtenstein KA, Glueck DH, Gourley PJ, Stamm ER, Scherzinger AL, Eckel RH.

AIDS. 2001 Oct 19;15(15):1993-2000.

PMID:
11600828
7.

Clinical lipoatrophy in HIV-1 patients on HAART is not associated with increased abdominal girth, hyperlipidaemia or glucose intolerance.

Worm D, Kirk O, Andersen O, Vinten J, Gerstoft J, Katzenstein TL, Nielsen H, Pedersen C.

HIV Med. 2002 Oct;3(4):239-46.

8.

Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.

Buffet M, Schwarzinger M, Amellal B, Gourlain K, Bui P, Prévot M, Deleuze J, Morini JP, Gorin I, Calvez V, Dupin N.

J Clin Virol. 2005 May;33(1):60-4.

PMID:
15797366
9.

Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.

Mulligan K, Tai VW, Algren H, Abrams DI, Leiser RJ, Lo JC, Schambelan M.

J Acquir Immune Defic Syndr. 2001 Apr 15;26(5):443-8.

PMID:
11391163
10.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
11.

Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.

Estrada V, Serrano-Ríos M, Martínez Larrad MT, Villar NG, González López A, Téllez MJ, Fernández C.

J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):32-40.

PMID:
11782587
13.

The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.

Carter VM, Hoy JF, Bailey M, Colman PG, Nyulasi I, Mijch AM.

HIV Med. 2001 Jul;2(3):174-80.

14.
16.

HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.

Miller J, Carr A, Emery S, Law M, Mallal S, Baker D, Smith D, Kaldor J, Cooper DA.

HIV Med. 2003 Jul;4(3):293-301.

17.

Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.

Mallal SA, John M, Moore CB, James IR, McKinnon EJ.

AIDS. 2000 Jul 7;14(10):1309-16.

PMID:
10930144
18.

Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.

Young J, Rickenbach M, Weber R, Furrer H, Bernasconi E, Hirschel B, Tarr PE, Vernazza P, Battegay M, Bucher HC.

Antivir Ther. 2005;10(1):73-81.

PMID:
15751765
19.

Effects of zidovudine, stavudine and beta-aminoisobutyric acid on lipid homeostasis in mice: possible role in human fat wasting.

Maisonneuve C, Igoudjil A, Begriche K, Lettéron P, Guimont MC, Bastin J, Laigneau JP, Pessayre D, Fromenty B.

Antivir Ther. 2004 Oct;9(5):801-10.

PMID:
15535418
20.

Does race protect an oriental population from developing lipodystrophy in HIV-infected individuals on HAART?

Chang KH, Kim JM, Song YG, Hong SK, Lee HC, Lim SK.

J Infect. 2002 Jan;44(1):33-8.

PMID:
11972416

Supplemental Content

Support Center